COMMONWEALTH EQUITY SERVICES, LLC
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 312272
WALTHAM, MA
Position in LCTX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$162,468
-$11,657 QoQ
Shares Held
102,828
-1.4% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $113,564,491 across 120 Biotechnology names. LCTX ranks #71 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,972 | $24,547,196 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,385 | $12,659,706 | |
| 3 | EXEL |
Exelixis, Inc.
|
173,762 | $7,452,652 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
180,285 | $5,989,067 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
80,892 | $5,674,573 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
78,488 | $3,733,674 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,577 | $3,499,611 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,076 | $3,453,265 |
All Filings in LCTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $162,468 | 102,828 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $174,125 | 104,267 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $170,558 | 100,922 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $55,985 | 61,522 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $26,418 | 58,708 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $29,354 | 58,708 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $43,917 | 48,261 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $47,761 | 47,761 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $70,686 | 47,761 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $52,059 | 47,761 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $64,288 | 54,482 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $72,589 | 51,482 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $72,733 | 48,489 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $57,317 | 48,989 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $48,578 | 42,990 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $71,874 | 45,490 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $70,053 | 45,489 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $94,641 | 38,629 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $110,726 | 43,939 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $154,866 | 54,339 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $113,563 | 48,325 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $158,099 | 89,829 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $85,933 | 91,419 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $74,314 | 85,419 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $62,107 | 74,828 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||